IBDEI0B8 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14950,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,14951,0)
 ;;=280.9^^101^900^9
 ;;^UTILITY(U,$J,358.3,14951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14951,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,14951,1,5,0)
 ;;=5^Iron Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,14951,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,14952,0)
 ;;=162.9^^101^900^10
 ;;^UTILITY(U,$J,358.3,14952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14952,1,4,0)
 ;;=4^162.9
 ;;^UTILITY(U,$J,358.3,14952,1,5,0)
 ;;=5^Lung CA, NOS
 ;;^UTILITY(U,$J,358.3,14952,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,14953,0)
 ;;=202.80^^101^900^11
 ;;^UTILITY(U,$J,358.3,14953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14953,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,14953,1,5,0)
 ;;=5^Lymphoma, Unsp Site
 ;;^UTILITY(U,$J,358.3,14953,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,14954,0)
 ;;=203.01^^101^900^12
 ;;^UTILITY(U,$J,358.3,14954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14954,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,14954,1,5,0)
 ;;=5^Mult Myeloma, In Remission
 ;;^UTILITY(U,$J,358.3,14954,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,14955,0)
 ;;=157.9^^101^900^13
 ;;^UTILITY(U,$J,358.3,14955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14955,1,4,0)
 ;;=4^157.9
 ;;^UTILITY(U,$J,358.3,14955,1,5,0)
 ;;=5^Pancreas CA, NOS
 ;;^UTILITY(U,$J,358.3,14955,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,14956,0)
 ;;=185.^^101^900^14
 ;;^UTILITY(U,$J,358.3,14956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14956,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,14956,1,5,0)
 ;;=5^Prostate CA
 ;;^UTILITY(U,$J,358.3,14956,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,14957,0)
 ;;=112.1^^101^901^1
 ;;^UTILITY(U,$J,358.3,14957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14957,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,14957,1,5,0)
 ;;=5^Candidal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,14957,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,14958,0)
 ;;=363.20^^101^901^2
 ;;^UTILITY(U,$J,358.3,14958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14958,1,4,0)
 ;;=4^363.20
 ;;^UTILITY(U,$J,358.3,14958,1,5,0)
 ;;=5^Chorioretinitis NOS
 ;;^UTILITY(U,$J,358.3,14958,2)
 ;;=^23913
 ;;^UTILITY(U,$J,358.3,14959,0)
 ;;=321.0^^101^901^3
 ;;^UTILITY(U,$J,358.3,14959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14959,1,4,0)
 ;;=4^321.0
 ;;^UTILITY(U,$J,358.3,14959,1,5,0)
 ;;=5^Cryptococcal Meningitis
 ;;^UTILITY(U,$J,358.3,14959,2)
 ;;=^186200
 ;;^UTILITY(U,$J,358.3,14960,0)
 ;;=117.5^^101^901^4
 ;;^UTILITY(U,$J,358.3,14960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14960,1,4,0)
 ;;=4^117.5
 ;;^UTILITY(U,$J,358.3,14960,1,5,0)
 ;;=5^Cryptococcosis
 ;;^UTILITY(U,$J,358.3,14960,2)
 ;;=^29608
 ;;^UTILITY(U,$J,358.3,14961,0)
 ;;=288.02^^101^901^5
 ;;^UTILITY(U,$J,358.3,14961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14961,1,4,0)
 ;;=4^288.02
 ;;^UTILITY(U,$J,358.3,14961,1,5,0)
 ;;=5^Cyclic Neutropenia
 ;;^UTILITY(U,$J,358.3,14961,2)
 ;;=^334039
 ;;^UTILITY(U,$J,358.3,14962,0)
 ;;=078.5^^101^901^6
 ;;^UTILITY(U,$J,358.3,14962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14962,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,14962,1,5,0)
 ;;=5^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,14962,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,14963,0)
 ;;=110.5^^101^901^7
 ;;^UTILITY(U,$J,358.3,14963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14963,1,4,0)
 ;;=4^110.5
 ;;^UTILITY(U,$J,358.3,14963,1,5,0)
 ;;=5^Dermatophytosis of Body
 ;;^UTILITY(U,$J,358.3,14963,2)
 ;;=^33179
 ;;^UTILITY(U,$J,358.3,14964,0)
 ;;=110.4^^101^901^8
 ;;^UTILITY(U,$J,358.3,14964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14964,1,4,0)
 ;;=4^110.4
 ;;^UTILITY(U,$J,358.3,14964,1,5,0)
 ;;=5^Dermatophytosis of Foot
 ;;^UTILITY(U,$J,358.3,14964,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,14965,0)
 ;;=288.03^^101^901^9
 ;;^UTILITY(U,$J,358.3,14965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14965,1,4,0)
 ;;=4^288.03
 ;;^UTILITY(U,$J,358.3,14965,1,5,0)
 ;;=5^Drug Induced Neutropenia
 ;;^UTILITY(U,$J,358.3,14965,2)
 ;;=^334040
 ;;^UTILITY(U,$J,358.3,14966,0)
 ;;=054.10^^101^901^10
 ;;^UTILITY(U,$J,358.3,14966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14966,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,14966,1,5,0)
 ;;=5^Genital Herpes
 ;;^UTILITY(U,$J,358.3,14966,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,14967,0)
 ;;=070.51^^101^901^11
 ;;^UTILITY(U,$J,358.3,14967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14967,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,14967,1,5,0)
 ;;=5^Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,14967,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,14968,0)
 ;;=053.9^^101^901^12
 ;;^UTILITY(U,$J,358.3,14968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14968,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,14968,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,14968,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,14969,0)
 ;;=042.^^101^901^13
 ;;^UTILITY(U,$J,358.3,14969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14969,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,14969,1,5,0)
 ;;=5^HIV Disease
 ;;^UTILITY(U,$J,358.3,14969,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,14970,0)
 ;;=V15.81^^101^901^14
 ;;^UTILITY(U,$J,358.3,14970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14970,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,14970,1,5,0)
 ;;=5^HX of Past Noncompliance
 ;;^UTILITY(U,$J,358.3,14970,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,14971,0)
 ;;=356.9^^101^901^15
 ;;^UTILITY(U,$J,358.3,14971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14971,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,14971,1,5,0)
 ;;=5^Idiopathic Neuropathy
 ;;^UTILITY(U,$J,358.3,14971,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,14972,0)
 ;;=V68.1^^101^901^16
 ;;^UTILITY(U,$J,358.3,14972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14972,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,14972,1,5,0)
 ;;=5^Issue Repeat Prescription
 ;;^UTILITY(U,$J,358.3,14972,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,14973,0)
 ;;=176.0^^101^901^17
 ;;^UTILITY(U,$J,358.3,14973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14973,1,4,0)
 ;;=4^176.0
 ;;^UTILITY(U,$J,358.3,14973,1,5,0)
 ;;=5^Kaposi's Sarcoma, Skin
 ;;^UTILITY(U,$J,358.3,14973,2)
 ;;=^267206
 ;;^UTILITY(U,$J,358.3,14974,0)
 ;;=528.6^^101^901^18
 ;;^UTILITY(U,$J,358.3,14974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14974,1,4,0)
 ;;=4^528.6
 ;;^UTILITY(U,$J,358.3,14974,1,5,0)
 ;;=5^Leukoplakia Oral Mucosa
 ;;^UTILITY(U,$J,358.3,14974,2)
 ;;=^270054
 ;;^UTILITY(U,$J,358.3,14975,0)
 ;;=136.3^^101^901^19
 ;;^UTILITY(U,$J,358.3,14975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14975,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,14975,1,5,0)
 ;;=5^Neumocystosis
 ;;^UTILITY(U,$J,358.3,14975,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,14976,0)
 ;;=288.09^^101^901^21
 ;;^UTILITY(U,$J,358.3,14976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14976,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,14976,1,5,0)
 ;;=5^Neutropenia NEC
 ;;^UTILITY(U,$J,358.3,14976,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,14977,0)
 ;;=288.00^^101^901^22
 ;;^UTILITY(U,$J,358.3,14977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14977,1,4,0)
 ;;=4^288.00
 ;;^UTILITY(U,$J,358.3,14977,1,5,0)
 ;;=5^Neutropenia NOS
 ;;^UTILITY(U,$J,358.3,14977,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,14978,0)
 ;;=795.71^^101^901^23
 ;;^UTILITY(U,$J,358.3,14978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14978,1,4,0)
 ;;=4^795.71
 ;;^UTILITY(U,$J,358.3,14978,1,5,0)
 ;;=5^Nonspec Serol Evid of HIV
 ;;^UTILITY(U,$J,358.3,14978,2)
 ;;=^303351
 ;;^UTILITY(U,$J,358.3,14979,0)
 ;;=294.8^^101^901^24
 ;;^UTILITY(U,$J,358.3,14979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14979,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,14979,1,5,0)
 ;;=5^Organic Brain Synd NEC
 ;;^UTILITY(U,$J,358.3,14979,2)
 ;;=^331843
 ;;^UTILITY(U,$J,358.3,14980,0)
 ;;=486.^^101^901^25
 ;;^UTILITY(U,$J,358.3,14980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14980,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,14980,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,14980,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,14981,0)
 ;;=782.1^^101^901^26
 ;;^UTILITY(U,$J,358.3,14981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14981,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,14981,1,5,0)
 ;;=5^Rash/Skin Eruption NOS
 ;;^UTILITY(U,$J,358.3,14981,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,14982,0)
 ;;=491.0^^101^901^27
 ;;^UTILITY(U,$J,358.3,14982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14982,1,4,0)
 ;;=4^491.0
 ;;^UTILITY(U,$J,358.3,14982,1,5,0)
 ;;=5^Simple Chr Bronchitis
 ;;^UTILITY(U,$J,358.3,14982,2)
 ;;=^269946
 ;;^UTILITY(U,$J,358.3,14983,0)
 ;;=097.9^^101^901^28
 ;;^UTILITY(U,$J,358.3,14983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14983,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,14983,1,5,0)
 ;;=5^Syphilis
 ;;^UTILITY(U,$J,358.3,14983,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,14984,0)
 ;;=288.04^^101^901^20
 ;;^UTILITY(U,$J,358.3,14984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14984,1,4,0)
 ;;=4^288.04
 ;;^UTILITY(U,$J,358.3,14984,1,5,0)
 ;;=5^Neutropenia D/T Infection
 ;;^UTILITY(U,$J,358.3,14984,2)
 ;;=^334041
 ;;^UTILITY(U,$J,358.3,14985,0)
 ;;=596.59^^101^902^1
 ;;^UTILITY(U,$J,358.3,14985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14985,1,4,0)
 ;;=4^596.59
 ;;^UTILITY(U,$J,358.3,14985,1,5,0)
 ;;=5^Bladder Dysfunction
 ;;^UTILITY(U,$J,358.3,14985,2)
 ;;=^270393
 ;;^UTILITY(U,$J,358.3,14986,0)
 ;;=600.01^^101^902^2
 ;;^UTILITY(U,$J,358.3,14986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14986,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,14986,1,5,0)
 ;;=5^BPH w/ Urinary Obstruc
 ;;^UTILITY(U,$J,358.3,14986,2)
 ;;=^334256
 ;;^UTILITY(U,$J,358.3,14987,0)
 ;;=600.00^^101^902^3
 ;;^UTILITY(U,$J,358.3,14987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14987,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,14987,1,5,0)
 ;;=5^BPH w/o Urinary Obstruc
 ;;^UTILITY(U,$J,358.3,14987,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,14988,0)
 ;;=099.50^^101^902^4
 ;;^UTILITY(U,$J,358.3,14988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14988,1,4,0)
 ;;=4^099.50
